CHICAGO A paper published in this week's Journal of Clinical Oncology says Transforming Growth Factor Beta Receptor 1*6A (TGFBR1*6A) a mutated gene present in nearly one in eight people and the most commonly inherited cancer susceptibility gene identified so far might be responsible for a significant proportion of familial colorectal cancers. The study, published by researchers at Northwestern Memorial Hospital and Northwestern University's Robert H. Lurie Comprehensive Cancer Center, says 15 to 20 percent of all colorectal cancers are familial, but only 7-8 percent are caused by mutations of known colorectal cancer genes such as the APC, MLH1, MSH2 and MSH6 genes.
In an earlier study, Dr. Pasche and his colleagues had found that TGFBR1*6A may increase the risk for all colon cancers by 20 percent. "There is growing evidence that TGFBR1*6A is associated with an increased risk of colorectal cancer but its specific contribution to familial colorectal cancer was unknown," explained Dr. Pasche. Now, Dr. Pasche believes the gene is especially potent as a cause for familial colon cancers.
The study looked at 208 patients with colorectal cancer and a strong family history of colorectal cancer and found that the number of TGFBR1*6A carriers was twice as high among patients without a mutation in the colorectal cancer genes MLH1, MSH2 and MSH6 as compared with patients without a mutation in these genes. The number of carriers of two copies of the TGFBR1*6A gene was 13-fold higher than in the general population, suggesting that TGFBR1*6A homozygosity (possessing two identical forms of a particular gene, one inherited from each parent) is associated with a particularly high risk of colorectal cancer.
Colorectal cancers are the second leading cause of cancer death among adult Americans and familial colorectal cancer is a major public health problem because it causes a relatively large percentage of these cancers. "We wanted to identify the genes resPage: 1 2 Related medicine news :1
Contact: Amanda Widtfeldt
Northwestern Memorial Hospital
. Northwesterns cancer genetics program finds gene variants that greatly increase breast cancer risk2
. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men3
. Survival differences by race most apparent in advanced stages of breast cancer4
. Stomach cancer rate set to fall further 25 percent over next decade5
. MRI finds breast cancer before it becomes dangerous6
. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer7
. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi8
. Pathway links inflammation, angiogenesis and breast cancer9
. Using MRI for diagnosis could help prevent breast cancer progression10
. Electric fields have potential as a cancer treatment11
. Shining light on pancreatic cancer